Advanced Search

 

Study ID Status Title Patient Level Data
29060/073 Completed A Multicentre, Double-blind Randomised Dose Titration Study Comparing the Efficacy and Safety Profiles of an Increasing Dose Regimen of Oral Paroxetine and Oral Amitriptyline in Adult Patients with Major Depression
29060/075 Completed A Sub-Chronic Comparison of the Effects of Paroxetine Versus those of Amitriptyline and Placebo on Fundamental Perceptual-Motor Skills and Actual Driving Performance
29060/076 Completed The Effects of Paroxetine Versus Those of Maprotiline and Placebo on Fundamental Cognitive Functions, Perceptual-Motor Skills and Eye Movements in Depressed Patients
29060/078 Completed A Multicentre Double Blind Study Comparing Paroxetine at a Dose of 20mq Increasing to 30mg Taken in the Morning and Amitriptyline 75mg Increasing to 150mg in Divided Doses in Adult Patients with Major Depressive Disorder
29060/079 Completed A double-blind comparative multicentre study comparing paroxetine b.d. (twice daily) with fluoxetine (Prozac®) b.d. (twice daily) in depressed patients
29060/082 Completed A Double-blind Comparative Multicentre Study Comparing Paroxetine 20-40mg/day with Maprotiline 50-150mg/day in Major Depression
29060/083 Completed A Double-blind Comparative Multicentre Study of Paroxetine and Placebo in Preventing Depressive Episodes in Recurrent Major Depressive Disorders
29060/084 Completed A Double Blind Comparative Study of the Effects of Paroxetine and Clomipramine on Cognitive Function in Elderly Patients with Major Depression
29060/086 Completed A Controlled Double-blind Randomised Parallel Group Study Comparing the Effects of Paroxetine and Maprotiline in the Treatment of Out-Patients with Major and Minor Depression
29060/087 Completed A double-blind, randomised, multicentre study comparing paroxetine 20mg daily versus fluoxetine 20mg daily in the treatment of adults with major depression with regard to antidepressant efficacy, tolerance and anxiolytic effect.
29060/088 Completed A Report on a Randomised, Double-Blind Comparative Study Including Evaluation of Effect Profiles and Correlations Between Plasma Concentration and Effect.
29060/089 Completed A Double-Blind Study to Compare the Efficacy and Tolerability of Paroxetine with Imipramine in Depressed Patients: An Interim Report (A final report has not been prepared and is not expected for this study).
29060/090 Completed Paroxetine and Imipramine in the Treatment of Depressive States in Psychiatric Specialist Practice - a Double-Blind Controlled Group Comparison
29060/091 Completed A study to investigate the effects of co-administration of three anticonvulsants (carbamazepine, valproate and phenytoin) and paroxetine in epileptic patients.
29060/092 Completed A double-blind, between patient, multicentre study comparing the efficacy, tolerability and effects on cognitive function of paroxetine with those of lofepramine in depressed patients in general practice
29060/094 Completed A Double-Blind Study to Assess The Safety And Tolerability of Paroxetine 60mg And To Compare Two Dosing Regimens
29060/095 Completed A double-blind comparative study of withdrawal effects following abrupt discontinuation of treatment with paroxetine in low or high dose or imipramine
29060/097 Completed ECT and paroxetine/imipramine combination treatment in depressive states. A clinical study of the safety of co-administration of ECT and paroxetine or imipramine, and relapse prevention in the maintenance phase.
29060/103 Completed A Double-Blind, Multicentre Study Comparing the Efficacy, Tolerability and Effects on Cognitive Functionof Paroxetine With Those of Lofepramine in Elderly Depressed Hospital In- or Out-Patients
29060/105 Completed An open study to investigate the effects of paroxetine (30 mg OD for 14 days) on sparteine oxidasepolymorphism in healthy volunteer subjects.
29060/106 Completed A double-blind comparative study of paroxetine and placebo in the treatment of episodes of intermittent brief depression (IBD) Study Listed on ClinicalStudyDataRequest.com
29060/108 Completed Paroxetine in Panic Disorder. A double-blind, randomised, multi-centre, placebo-controlled study of paroxetine in combination with psychotherapy in the treatment of patients with panic disorder (DSM-III-R).
29060/109 Completed A double-blind, short-term comparison of paroxetine and amitriptyline with a 12-month, rater-blind maintenance phase comparing paroxetine, amitriptyline and lithium in the prevention of depressive relapse in patients with major depression, recurrent.
29060/110 Completed A double-blind, placebo-controlled study to assess the effects of paroxetine on the bleeding time of healthy volunteers
29060/112 Completed A double-blind, multicentre study to compare the effectiveness and tolerance of paroxetine versus fluvoxamine in depressed patients

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.